Breaking Down NovoCure: 4 Analysts Share Their Views
Breaking Down NovoCure: 4 Analysts Share Their Views
解析NovoCure：4位分析师分享他们的观点
Investigating Analyst Ratings...4 analysts have expressed a variety of opinions on NovoCure (NASDAQ:NVCR) over the past quarter, offering a diverse set of opinions from bullish to bearish.
过去一个季度，有4位分析师对NovoCure (纳斯达克股票代码：NVCR) 发表了不同的意见，从看好到看淡的看法不一。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.0, a high estimate of $28.00, and a low estimate of $20.00. This current average reflects an increase of 7.58% from the previous average price target of $21.38.
分析师们通过对未来12个月的目标股价的评估，提供了更深入的见解，揭示了一个平均目标价为$23.0，最高估价为$28.0，最低估价为$20.0的多元化观点，这一当前平均值相对于之前的平均目标股价$21.38，增长了7.58%。
Investigating Analyst Ratings...
分析师...
登录免费看全文
登录/注册